What is Savara Inc's earnings per share (EPS)?

Savara Inc (SVRA) reported diluted earnings per share of $-0.53 for fiscal year 2025. This represents a -10.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Savara Inc Financials

SVRA

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Savara Inc (SVRA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 29 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak

2/9

Savara Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality

0.85x

For every $1 of reported earnings, Savara Inc generates $0.85 in operating cash flow (-$101.0M OCF vs -$118.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$123.5M

YoY-19.8%

Savara Inc's EBITDA was -$123.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 19.8% from the prior year.

Net Income

-$118.8M

YoY-23.9%

Savara Inc reported -$118.8M in net income in fiscal year 2025. This represents a decrease of 23.9% from the prior year.

EPS (Diluted)

$-0.53

YoY-10.4%

Savara Inc earned $-0.53 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 10.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$101.1M

YoY-13.4%

Savara Inc generated -$101.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 13.4% from the prior year.

Cash & Debt

$33.2M

YoY+119.3%

5Y CAGR+7.7%

10Y CAGR+7.1%

Savara Inc held $33.2M in cash against $29.9M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

205M

YoY+18.6%

5Y CAGR+30.4%

Savara Inc had 205M shares outstanding in fiscal year 2025. This represents an increase of 18.6% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-58.5%

YoY-2.6pp

5Y CAGR+18.6pp

Savara Inc's ROE was -58.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.6 percentage points from the prior year.

Capital Allocation

R&D Spending

$81.4M

YoY+4.3%

5Y CAGR+18.4%

10Y CAGR+34.1%

Savara Inc invested $81.4M in research and development in fiscal year 2025. This represents an increase of 4.3% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$22K

YoY-12.0%

5Y CAGR-14.1%

10Y CAGR-18.2%

Savara Inc invested $22K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 12.0% from the prior year.

SVRA Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	$257K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$81.4M+4.3%	$78.0M+76.3%	$44.3M+58.8%	$27.9M-3.8%	$29.0M-17.3%	$35.0M
SG&A Expenses	$42.1M+68.0%	$25.0M+59.8%	$15.7M+43.4%	$10.9M-11.5%	$12.3M-13.4%	$14.3M
Operating Income	-$123.5M-19.7%	-$103.2M-72.0%	-$60.0M-54.5%	-$38.8M+6.4%	-$41.5M+15.9%	-$49.3M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0-100.0%	$9K	N/A	N/A	N/A	N/A
Net Income	-$118.8M-23.9%	-$95.9M-75.3%	-$54.7M-43.4%	-$38.1M+11.3%	-$43.0M+13.3%	-$49.6M
EPS (Diluted)	$-0.53-10.4%	$-0.48-45.5%	$-0.33-32.0%	$-0.25+21.9%	$-0.32	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	$20.6M-0.8%	$20.8M+8.3%	$19.2M	N/A	$20.3M+15.3%	$17.6M+4.8%	$16.8M
SG&A Expenses	N/A	$9.6M-9.6%	$10.7M+15.2%	$9.2M	N/A	$6.0M+8.5%	$5.5M-1.7%	$5.6M
Operating Income	N/A	-$30.3M+3.8%	-$31.4M-10.6%	-$28.4M	N/A	-$26.4M-13.7%	-$23.2M-3.2%	-$22.5M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$29.6M+2.8%	-$30.4M-14.1%	-$26.6M	N/A	-$24.2M-9.0%	-$22.2M-9.3%	-$20.3M
EPS (Diluted)	N/A	$-0.140.0%	$-0.14-16.7%	$-0.12	N/A	$-0.11+8.3%	$-0.12-9.1%	$-0.11

SVRA Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$253.4M+19.1%	$212.9M+19.9%	$177.6M+27.0%	$139.8M-20.9%	$176.6M+80.7%	$97.7M
Current Assets	$241.6M+19.5%	$202.1M+21.8%	$165.9M+28.7%	$129.0M-21.8%	$165.0M+93.8%	$85.1M
Cash & Equivalents	$33.2M+119.3%	$15.1M-43.1%	$26.6M-49.0%	$52.1M+53.2%	$34.0M+48.7%	$22.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	$0
Total Liabilities	$50.3M+21.4%	$41.4M+11.4%	$37.2M+16.2%	$32.0M-0.3%	$32.1M-3.8%	$33.4M
Current Liabilities	$20.4M+38.5%	$14.7M+38.9%	$10.6M+80.6%	$5.9M-60.0%	$14.7M+79.3%	$8.2M
Long-Term Debt	$29.9M+12.4%	$26.6M+1.0%	$26.3M+1.0%	$26.1M+50.5%	$17.3M-31.0%	$25.1M
Total Equity	$203.1M+18.5%	$171.4M+22.1%	$140.4M+30.2%	$107.8M-25.4%	$144.5M+124.4%	$64.4M
Retained Earnings	-$608.1M-24.3%	-$489.3M-24.4%	-$393.4M-16.2%	-$338.7M-12.7%	-$300.5M-16.7%	-$257.5M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$253.4M+79.8%	$140.9M-13.9%	$163.8M-13.5%	$189.3M-11.1%	$212.9M-10.9%	$238.8M+71.0%	$139.7M-11.8%	$158.3M
Current Assets	$241.6M+88.5%	$128.2M-15.1%	$151.0M-14.9%	$177.4M-12.2%	$202.1M-10.7%	$226.4M+77.3%	$127.7M-12.7%	$146.2M
Cash & Equivalents	$33.2M+103.8%	$16.3M-6.6%	$17.4M-10.8%	$19.6M+29.3%	$15.1M-29.4%	$21.4M-10.2%	$23.9M+42.2%	$16.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$50.3M+8.1%	$46.5M+7.5%	$43.3M+4.4%	$41.5M+0.1%	$41.4M+5.0%	$39.5M+4.0%	$37.9M+4.1%	$36.4M
Current Liabilities	$20.4M+21.7%	$16.8M+23.0%	$13.6M+14.5%	$11.9M-19.2%	$14.7M+15.1%	$12.8M+13.3%	$11.3M+15.0%	$9.8M
Long-Term Debt	$29.9M+0.4%	$29.8M+0.4%	$29.7M+0.4%	$29.5M+10.9%	$26.6M+0.3%	$26.6M+0.3%	$26.5M+0.3%	$26.4M
Total Equity	$203.1M+115.2%	$94.4M-21.7%	$120.5M-18.5%	$147.8M-13.8%	$171.4M-14.0%	$199.3M+96.0%	$101.7M-16.5%	$121.9M
Retained Earnings	-$608.1M-5.6%	-$575.9M-5.4%	-$546.3M-5.9%	-$515.9M-5.4%	-$489.3M-6.3%	-$460.2M-5.6%	-$436.0M-5.4%	-$413.7M

SVRA Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$101.0M-13.4%	-$89.1M-74.5%	-$51.1M-47.8%	-$34.6M+13.8%	-$40.1M-0.6%	-$39.8M
Capital Expenditures	$22K-12.0%	$25K-91.6%	$296K+3188.9%	$9K-84.2%	$57K+21.3%	$47K
Free Cash Flow	-$101.1M-13.4%	-$89.1M-73.5%	-$51.4M-48.6%	-$34.6M+13.9%	-$40.1M-0.6%	-$39.9M
Investing Cash Flow	-$18.4M+53.8%	-$39.9M+30.1%	-$57.1M-208.5%	$52.6M+175.8%	-$69.5M-867.2%	$9.1M
Financing Cash Flow	$137.8M+17.2%	$117.6M+42.0%	$82.8M+95049.4%	$87K-99.9%	$120.8M+3174.8%	$3.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$25.1M-11.2%	-$22.5M+14.2%	-$26.3M+3.4%	-$27.2M-16.8%	-$23.3M-2.7%	-$22.7M-0.8%	-$22.5M-9.0%	-$20.6M
Capital Expenditures	$2K0.0%	$2K-86.7%	$15K+400.0%	$3K+133.3%	-$9K-400.0%	$3K-85.7%	$21K+110.0%	$10K
Free Cash Flow	-$25.1M-11.2%	-$22.5M+14.2%	-$26.3M+3.4%	-$27.2M-16.8%	-$23.3M-2.7%	-$22.7M-0.7%	-$22.5M-9.0%	-$20.7M
Investing Cash Flow	-$93.6M-535.8%	$21.5M-11.8%	$24.3M-17.1%	$29.3M+63.9%	$17.9M+118.2%	-$98.2M-432.3%	$29.5M+173.7%	$10.8M
Financing Cash Flow	$135.6M+589491.3%	-$23K+53.1%	-$49K-102.1%	$2.3M+375.0%	-$843K-100.7%	$118.3M+215020.0%	$55K+12.2%	$49K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SVRA Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	-19182.9%
Net Margin	N/A	N/A	N/A	N/A	N/A	-19305.5%
Return on Equity	-58.5%-2.6pp	-55.9%-17.0pp	-39.0%-3.6pp	-35.4%-5.6pp	-29.8%+47.3pp	-77.1%
Return on Assets	-46.9%-1.8pp	-45.0%-14.2pp	-30.8%-3.5pp	-27.3%-2.9pp	-24.4%+26.4pp	-50.8%
Current Ratio	11.85-1.9	13.73-1.9	15.66-6.3	21.98+10.7	11.26+0.8	10.41
Debt-to-Equity	0.150.0	0.16-0.0	0.19-0.1	0.24+0.1	0.12-0.3	0.39
FCF Margin	N/A	N/A	N/A	N/A	N/A	-15518.7%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	-31.3%-6.1pp	-25.2%-7.2pp	-18.0%	N/A	-12.2%+9.7pp	-21.9%-5.2pp	-16.7%
Return on Assets	N/A	-21.0%-2.4pp	-18.6%-4.5pp	-14.1%	N/A	-10.2%+5.8pp	-15.9%-3.1pp	-12.8%
Current Ratio	11.85+4.2	7.65-3.4	11.08-3.8	14.91+1.2	13.73-4.0	17.70+6.4	11.31-3.6	14.90
Debt-to-Equity	0.15-0.2	0.32+0.1	0.25+0.0	0.20+0.0	0.16+0.0	0.13-0.1	0.26+0.0	0.22
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Palvella Therapeutics Inc PVLA

$1.8B

Oruka Therapeutics Inc ORKA

$2.6B

Anaptysbio Inc ANAB

$1.7B

Septerna, Inc. SEPN

$1.1B

Keros Therapeutics, Inc. KROS

$236.6M

Frequently Asked Questions

Is Savara Inc profitable?

No, Savara Inc (SVRA) reported a net income of -$118.8M in fiscal year 2025.

What is Savara Inc's EBITDA?

Savara Inc (SVRA) had EBITDA of -$123.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Savara Inc have?

As of fiscal year 2025, Savara Inc (SVRA) had $33.2M in cash and equivalents against $29.9M in long-term debt.

What is Savara Inc's return on equity (ROE)?

Savara Inc (SVRA) has a return on equity of -58.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Savara Inc's free cash flow?

Savara Inc (SVRA) generated -$101.1M in free cash flow during fiscal year 2025. This represents a -13.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Savara Inc's operating cash flow?

Savara Inc (SVRA) generated -$101.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Savara Inc's total assets?

Savara Inc (SVRA) had $253.4M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Savara Inc's capital expenditures?

Savara Inc (SVRA) invested $22K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Savara Inc spend on research and development?

Savara Inc (SVRA) invested $81.4M in research and development during fiscal year 2025.

How many shares does Savara Inc have outstanding?

Savara Inc (SVRA) had 205M shares outstanding as of fiscal year 2025.

What is Savara Inc's current ratio?

Savara Inc (SVRA) had a current ratio of 11.85 as of fiscal year 2025, which is generally considered healthy.

What is Savara Inc's debt-to-equity ratio?

Savara Inc (SVRA) had a debt-to-equity ratio of 0.15 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Savara Inc's return on assets (ROA)?

Savara Inc (SVRA) had a return on assets of -46.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Savara Inc's cash runway?

Based on fiscal year 2025 data, Savara Inc (SVRA) had $33.2M in cash against an annual operating cash burn of $101.0M. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Savara Inc's Piotroski F-Score?

Savara Inc (SVRA) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Savara Inc's earnings high quality?

Savara Inc (SVRA) has an earnings quality ratio of 0.85x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.